Thalidomide
Showing 26 - 50 of 663
Multiple Myeloma Trial in Chengdu (Selinexor, Thalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Selinexor
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 13, 2021
Systemic Lupus Erythematosus (SLE), Juvenile SLE, Cutaneous Lupus Trial in São Paulo (Thalidomide, Hydroxychloroquine reduced,
Completed
- Systemic Lupus Erythematosus (SLE)
- +2 more
- Thalidomide
- +2 more
-
São Paulo, BrazilHospital das Clinicas da Faculdade de Medicina da USP
Dec 15, 2021
Multiple Myeloma, Chronic Kidney Disease Trial in United Kingdom (Bortezomib, Thalidomide, Bendamustine)
Completed
- Multiple Myeloma
- Chronic Kidney Disease
- Bortezomib
- +3 more
-
Basingstoke, United Kingdom
- +8 more
Jan 26, 2022
Multiple Myeloma Trial in New York (thalomid, lenalidomide, clarithromycin)
Completed
- Multiple Myeloma
- thalomid
- +3 more
-
New York, New YorkWeill Medical College of Cornell University
Apr 30, 2021
Multiple Myeloma Trial in Little Rock (Carfilzomib, Thalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +11 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 1, 2022
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)
Recruiting
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- pegaspargase
- +5 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021
Brain and CNS Tumors, Glioblastoma Multiforme Trial in United States (Celecoxib, Isotretinoin, Temozolomide)
Completed
- Brain and Central Nervous System Tumors
- Glioblastoma Multiforme
- Celecoxib
- +3 more
-
Fort Smith, Arkansas
- +11 more
Sep 21, 2021
Multiple Myeloma Trial in Torino (Bortezomib, Melphalan, Prednisone, Thalidomide, Bortezomib, Melphalan, Prednisone)
Completed
- Multiple Myeloma
- Bortezomib, Melphalan, Prednisone, Thalidomide
- Bortezomib, Melphalan, Prednisone
-
Torino, ItalyA.O.U. S. Giovanni Battista
Dec 22, 2020
Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC
Terminated
- Multiple Myeloma
- myPRS
- +6 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
May 28, 2021
Multiple Myeloma Trial in Little Rock (M-VTD-PACE, TT3-LITE Regimen (L-TT3))
Active, not recruiting
- Multiple Myeloma
- M-VTD-PACE
- TT3-LITE Regimen (L-TT3)
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences, Myeloma Institute f
Oct 4, 2021
Chronic Radiation Proctitis Trial (Thalidomide)
Unknown status
- Chronic Radiation Proctitis
- Thalidomide
- (no location specified)
Dec 19, 2020
Non-small-cell Lung Cancer Trial in Shanghai (pyrotinib combined with thalidomide)
Recruiting
- Non-small-cell Lung Cancer
- pyrotinib combined with thalidomide
-
Shanghai, ChinaDepartment of Oncology, Shanghai Lung Cancer Center, Shanghai Ch
Jan 26, 2021
Amyloidosis Trial in United Kingdom (Carfilzomib, Thalidomide, Dexamethasone)
Tumors Metastatic to Brain Trial in Philadelphia (radiation, drug, procedure)
Completed
- Tumors Metastatic to Brain
- radiation therapy
- +2 more
-
Philadelphia, PennsylvaniaRadiation Therapy Oncology Group
Oct 29, 2020
Myeloma Trial in France (melphalan-prednisone-thalidomide, lenalidomide-dexamethasone)
Completed
- Myeloma
-
Albi, France
- +25 more
Mar 29, 2021
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Velcade (Bortezomib), Thalidomide, Dexamethasone)
Terminated
- Multiple Myeloma
- Velcade (Bortezomib)
- +2 more
-
Graz, Austria
- +80 more
Sep 21, 2021
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2020
HIV, Stomatitis, Aphthous Trial in Puerto Rico, United States (Thalidomide)
Completed
- HIV Infections
- Stomatitis, Aphthous
- Thalidomide
-
Birmingham, Alabama
- +39 more
Oct 27, 2021
Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor Trial in Saint Louis (Metronomic Cyclophosphamide, Thalidomide)
Recruiting
- Glioma
- +6 more
- Metronomic Cyclophosphamide
- Thalidomide
-
Saint Louis, MissouriWashington University School of Medicine
Sep 22, 2021
Immunoglobulin Light-Chain Amyloidosis Trial in Guangzhou (Thalidomide, Cyclophosphamide)
Recruiting
- Immunoglobulin Light-Chain Amyloidosis
- Thalidomide
- Cyclophosphamide
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People'S Hospital
Oct 27, 2020
Melanoma Trial in Houston (Temozolomide, Velban, Cisplatin)
Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)
Active, not recruiting
- Multiple Myeloma
- Velcade
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 7, 2021